The Journal of Organic Chemistry
Page 24 of 26
1
2
3
4
5
6
7
8
9
Lijanova, I. V.; Ukrainets, I. V.; Likhanova, N. V.; Olivares-Xometl, O.; Bereznyakova, N. L. New
Synthesis, Structure and Analgesic Properties of Methyl 1-R-4-Methyl-2,2-Dioxo-1H-2λ6,1-
Benzothiazine-3-Carboxylates. Sci. Pharm. 2017, 85, 2. (c) Ukrainets, I. V.; Hamza, G. M.; Burian, A.
A.; Shishkina, S. V.; Voloshchuk, N. I.; Malchenko, O. V. Sci. Pharm. 2018, 86, 9. (d) Ukrainets, I. V.;
Hamza, G. M.; Burian, A. A.; Voloshchuk, N. I.; Malchenko, O. V.; Shishkina, S. V.; Grinevich, L. A.;
Grynenko, V. V.; Sim, G. Molecular Conformations and Biological Activity of N-Hetaryl(aryl)alkyl-4-
methyl-2,2-dioxo-1H-2λ6,1-benzothiazine-3-carboxamides. Sci. Pharm. 2018, 86, 50.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(2) (a) Xie, Y.; Gong, G.; Liu, Y.; Deng, S.; Rinderspacher, A.; Branden, L.; Landry, D. W. Convenient
preparation of N-8-quinolinyl benzenesultams as novel NF-κB inhibitors. Tetrahedron Lett. 2008, 49,
2320. (b) Xie, Y.; Deng, S.; Thomas, C. J.; Liu, Y.; Zhang, Y.; Rinderspacher, A.; Huang, W.; Gong,
G.; Wyler, M.; Cayanis, E.; Aulner, N.; Toebben, U.; Chung, C.; Pampou, S.; Southall, N.; Vidovic, D.;
Schuerer, S.; Branden, L.; Davis, R. E.; Staudt, L. M.; Inglese, J.; Austin, C. P.; Landry, D. W.; Smith,
D. H.; Auld, D. S. Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-
regulating NF-κB activity within two separate high-throughput screens of NF-κB activation. Bioorg.
Med. Chem. Lett. 2008, 18, 329.
(3) (a) Tomita, N.; Hayashi, Y.; Suzuki, S.; Oomori, Y.; Aramaki, Y.; Matsushita, Y.; Iwatani, M.;
Iwata, H.; Okabe, A.; Awazu, Y.; Ison , O.; Skene , R. J.; Hosfield, D. J.; Miki, H.; Kawamoto, T.; Hori,
A.; Baba, A. Structure-based discovery of cellular-active allosteric inhibitors of FAK. Bioorg. Med.
Chem. Lett. 2013, 23, 1779. (b) Iwatani, M.; Iwata, H.; Okabe, A.; Skene, R. J.; Tomita, N.; Hayashi,
Y.; Aramaki, Yoshio; Hosfield, D. J.; Akira Hori, A.; Baba, A.; Miki, H. Discovery and characterization
of novel allosteric FAK inhibitors. Eur. J. Med. Chem. 2013, 61, 49.
(4) Pieroni, M.; Sabatini, S.; Massari, S.; Kaatz, G.W.; Cecchetti, V.; Tabarrini, O. Searching for
innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-
dioxide derivatives. MedChemComm 2012, 3, 1092.
(5) (a) I. Ukrainets, V.; Petrushova, L. A.; Dzyubenko, S. P. 2,1-Benzothiazine 2,2-Dioxides. 1.
Synthesis, Structure, and Analgesic Activity of 1-R-4-Hydroxy-2,2-Dioxo-1H-2λ6,1-Benzothiazine-3-
Carboxylic Acid Esters. Chem. Heterocycl. Compds 2013, 49, 1378. (b) Manfroni, G.; Meschini, F.;
Costantino, F.; Tabarrini, O.; Cecchettia, V. N-Benzoyl-N-methylsulfonyl anthranilates: unexpected
cyclization reaction to 4-alkoxy-2,1-benzothiazines. Arkivoc 2011, 165. (c) Jeon, M.; Kim, M.; Kwon,
J.; Gong, Y.; Lee, D. A solid-phase synthetic method for 3,4-dihydro-1H-2,1-benzothiazin-4-one 2,2-
dioxide derivatives. Tetrahedron 2008, 64, 9060.
(6) (a) Togo, H.; Harada, Y.; Yokoyama, M. Preparation of 3,4-Dihydro-2,1-benzothiazine 2,2-Dioxide
Skeleton from N-Methyl 2-(Aryl)ethanesulfonamides with (Diacetoxyiodo)arenes. J. Org. Chem.
24
ACS Paragon Plus Environment